Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

US pharmaceutical company Pfizer last week triumphed in a long-awaited court decision that, if upheld, will stop generics companies from copying its blockbuster cholesterol-lowering drug Lipitor until ...

BOSTON (MarketWatch) -- Pfizer shares lost ground Tuesday, following the release of mixed preliminary clinical data for a proposed follow-on product to its blockbuster cholesterol drug Lipitor. Shares ...

The $68 billion acquisition will solidify Pfizer’s standing as the top-selling drugmaker. Bottles of Pfizer’s Lipitor, left, and Wyeth’s Effexor are shown. Shareholders of Wyeth voted overwhelmingly ...

With it exclusive window on cholesterol drug Lipitor long closed, Pfizer is looking to the post-Lipitor world. WSJ's Spencer Jakab visits Mean Street to make the case that the company's future is ...

Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, ...

The pharmaceutical giant Pfizer will to pay a record $2.3 billion settlement for illegal drug promotion. Pfizer Inc. and its subsidiary Pharmacia & Upjohn will pay the settlement to resolve criminal ...

WASHINGTON -- Pfizer Inc. announced Monday it is pulling its Lipitor advertisements that feature the inventor of the artificial heart whose endorsement came under congressional fire earlier this year.